Inhibition by tiazofurin of inosine 5′-phosphate dehydrogenase (IMP DH) activity in extracts of ovarian carcinomas
- 31 October 1992
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 47 (1) , 66-70
- https://doi.org/10.1016/0090-8258(92)90078-w
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Tiazofurin: Biological effects and clinical usesThe International Journal of Cell Cloning, 1990
- Cancer statistics, 1990CA: A Cancer Journal for Clinicians, 1990
- Enzyme-pattern-targeted chemotherapy with tiazofurin and allopurinol in human leukemiaAdvances in Enzyme Regulation, 1988
- Selective sensitivity to tiazofurin of human leukemic cellsBiochemical Pharmacology, 1986
- Direct assay method for inosine 5′-monophosphate dehydrogenase activityAnalytical Biochemistry, 1985
- Action of 2-β-d-ribofuranosylthiazole-4-carboxamide (tiazofurin) against untreated human ovarian cancers in the murine xenograft assayGynecologic Oncology, 1985
- The conversion of 2-β-D-ribofuranosylthiazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory propertiesBiochemical Pharmacology, 1982
- Nucleoside and Nucleotide Inhibitors of Inosine Monophosphate (IMP) Dehydrogenase as Potential Antitumor InhibitorsNucleosides and Nucleotides, 1982
- Key enzymes of IMP metabolism: Transformation- and proliferation-linked alterations in gene expressionAdvances in Enzyme Regulation, 1976
- IMP dehydrogenase, an enzyme linked with proliferation and malignancyNature, 1975